Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TH1Z
|
||||
Former ID |
DIB009415
|
||||
Drug Name |
Naxagolide
|
||||
Synonyms |
Dopazinol; Nazagolide; PHNO; Naxagolide hydrochloride; L-647339; MK-458; (+)-PHNO
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Discontinued in Phase 2 | [545272] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H21NO2
|
||||
Canonical SMILES |
[C@@H]12c3c(CC[C@H]1N(CCO2)CCC)ccc(c3)O
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Modulator | [533809] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.